Irwin Redlener has pointed out that, in the event of a serious influenza outbreak – “pandemic” – which means that the high incidence of a given illness is greater than normal not only in one community (an epidemic) – but in a wider area than would normally be expected – we would be in sudden need of many more mechanical ventilators ((These ventilators are descendants of the “Iron Lung” and the 1928 “Drinker respirator.” See Wikipedia entry for “Mechanical Ventilator.”)) than are normally needed.
For instance, one credible – but not worst-case – scenario of avian influenza would leave New York State short 50,000 ventilators, and another with a nationwide shortfall of 700,000. The International Business Times has reported that a physician on the faculty at Stanford has developed a high-quality, low-cost ventilator.
The low-end model, called OneBreath, was designed by a team of researchers led by Matthew Callaghan, MD, at Stanford Biodesign, a training incubator in medical technology that brings together multidisciplinary teams of medical, engineering, law and business school students to address unmet medical needs with innovative approaches.
Callaghan says that the idea struck him first at a planning meeting at a hospital that was trying to formalize criteria to decide which type of patients would receive life support from the limited number of ventilators in the hospital should a scenario arise when emergency demand outstrips supply. Later, an alarming piece of statistics – that the United States would fall short of 700,000 ventilators in the event of a moderate-to-severe influenza pandemic – triggered the thought of commercialization of the innovation. Continue reading